Ligand validation:6ZI5

HTO: HEPTANE-1,2,3-TRIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZI5_HTO_H_708	24%	59%	0.251	0.881	0.79	0.79	-	-	0	0	100%	1
6ZI5_HTO_L_305	2%	57%	0.508	0.77	0.75	0.89	-	1	0	0	100%	1
3G7F_HTO_H_705	75%	66%	0.1	0.933	0.42	0.87	-	-	1	0	100%	1
6ZIA_HTO_H_710	53%	51%	0.138	0.899	0.85	1.04	-	1	0	0	100%	1
5O64_HTO_H_308	44%	46%	0.157	0.885	0.83	1.26	-	2	0	0	100%	1
3T6D_HTO_H_272	43%	38%	0.169	0.894	0.74	1.68	-	3	1	0	100%	0.75
6ZID_HTO_H_710	40%	51%	0.157	0.865	0.85	1.04	-	1	0	0	100%	1
2HPY_HTO_B_1401	79%	28%	0.103	0.95	1.81	1.1	2	1	1	0	100%	1
5IU8_HTO_A_2402	59%	12%	0.141	0.922	0.51	3.53	-	3	0	0	100%	1
3DTU_HTO_B_1	59%	73%	0.153	0.934	0.21	0.82	-	-	1	1	100%	1
4TSY_HTO_A_209	57%	40%	0.161	0.937	0.59	1.71	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.